Anna Kouraba/LinkedIn
Feb 6, 2026, 18:07
Anna Kouraba: Laiko Hospital’s Contribution to rFVIII Single Chain Real-World Evidence at EAHAD 2026
Anna Kouraba, Director Hematologist at Laiko General Hospital of Athens, shared on LinkedIn:
”EAHAD 2026, proud about Laiko Hospital, National Comprehensive Hemophilia Treatment Center, contribution at rFVIII Single Chain RWE poster”
More from EAHAD 2026 featured in Hemostasis Today.
-
Aug 14, 2026, 16:26Antonio Paul: The Best Transfusion Is the One That Isn’t Needed
-
Aug 14, 2026, 16:24Thirunavukkarasu Angappan: What mRNA Manufacturing Teaches Us About Scaling Hemophilia Gene Therapy
-
Aug 14, 2026, 16:16Priyanka Raheja: Advancing Multidisciplinary Care for Women with Bleeding Disorders
-
Aug 14, 2026, 16:09Cristina Chang: Hemophilia B Gene Therapy BBM-H901 Approved in Macao
-
Aug 14, 2026, 16:03Muhammad Shaheer Bin Faheem: The Growing Mortality Divide in Thromboembolism and Hypertension
-
Aug 14, 2026, 15:53Peter Jaworski: Plasma Donation Myths and Why Plasma Matters
-
Aug 14, 2026, 15:50John Strouse: Why Older Adults with Sickle Cell Disease Should Be Included in Clinical Trials
-
Aug 14, 2026, 15:44Scott Cameron: Understanding Sex Differences in Platelet Biology
-
Aug 14, 2026, 15:35Daniel Witt: Why Patient Education Matters in Anticoagulation Care